RNA, U6 small nuclear 122, pseudogene (RNU6-122P)

RNU6-122P, or RNA, U6 small nuclear 122, pseudogene, is a *pseudogene* of U6 small nuclear RNA. U6 snRNA is a highly conserved, non-coding RNA integral to the spliceosome, the multi-component molecular machinery required for the splicing of pre-mRNA in eukaryotic cells[1][3]. However, the “pseudogene” designation means that RNU6-122P is a non-functional genomic copy derived from the original U6 snRNA gene and lacks normal biological activity; it is not transcribed into a functional RNA or protein[4][5]. Pseudogenes like RNU6-122P arise through retrotransposition, duplication, or mutation events and are widespread in the genome, but do not have clear roles in normal physiology, disease, or as therapeutic targets[5]. RNU6-122P is not a receptor, enzyme, or any other classical drug target category, and there are no known drugs, biological functions, or disease associations for this pseudogene[4][5]. **Notes:** - This “target” is a pseudogene (not a protein/receptor/functional RNA). - It does *not* have therapeutic, diagnostic, or mechanistic relevance as a drug target. - Entry is considered “incorrect” as a drug target or for structured pharmacology purposes.

Other names

RNU6-122PRNA, U6 Small Nuclear 122, Pseudogene